Axonics Modulation Technologies has raised $59M in total funding. Latest round: Series B.
Axonics Modulation Technologies has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2015. The round record for Axonics Modulation Technologies runs through 2015; nothing later has been disclosed. Investors on record include Edmond de Rothschild Investment Partners, NeoMed Management, Legend Capital, Alfred E. Mann Foundation, Advent Life Sciences, Cormorant Asset Management. 6 distinct backers are named across the disclosed rounds.
Round data for Axonics Modulation Technologies is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026